Pediatric Cancer Predisposition Fellow Germline Genomics

St Jude Children's Research Hospital; Memphis (TN); On-site; USD 60,000 - 68,000; Full time

Benefits offered by this job

Professional development allowance

Research allowance

Tuition assistance

Dependent care assistance

Moving allowance

Retirement savings plan

Onsite health and fitness facility

Flexible health and dependent care SAV

Medical, dental and vision insurance (

Disability insurance

Long term disability

Group life insurance

Job summary

St. Jude Children's Research Hospital in Memphis is offering the St. Jude Fellowship in Pediatric Cancer Predisposition.

This one-year program provides advanced training in germline precision medicine and cancer genetics to optimize care for children with cancer. As a fellow, you will enhance clinical expertise in hereditary cancer predisposition, develop a multidisciplinary approach to management, and apply tumor and germline genomics to understand cancer risk and treatment implications for

Qualifications

• Fellowship focuses on pediatric cancer predisposition and germline genetics.
• Candidates should be ABP eligible in pediatric hematology-oncology or equivalent training.

Responsibilities

• Enhance clinical expertise in diagnosis and evaluation of hereditary cancer predisposition in children and AYAs.
• Develop a multidisciplinary approach to management.
• Apply tumor and germline genomic testing to understand cancer risk and treatment implications.

Skills

Germline genomics

Hereditary cancer predisposition

Multidisciplinary collaboration

Clinical oncology knowledge

Communication with families

Education

American Board of Pediatrics eligible

Job description

St. Jude Children's Research Hospital in Memphis is offering the St. Jude Fellowship in Pediatric Cancer Predisposition.

This one-year program provides advanced training in germline precision medicine and cancer genetics to optimize care for children with cancer. As a fellow, you will enhance clinical expertise in hereditary cancer predisposition, develop a multidisciplinary approach to management, and apply tumor and germline genomics to understand cancer risk and treatment implications for